What Are the Signs and Symptoms of Non-Melanoma Skin Cancer?

 

Signs and Symptoms of Basal and Squamous Cell Carcinomas

Basal and squamous cell carcinomas appear as a change in an area of the skin. This change may be an unusual looking bump or a patch of skin that is red or scaly. The most common sites for these cancers to occur are on the head and neck area, but they may develop anywhere on the skin. The most common signs of these cancers are:

  • A sore or lump that develops a scab and does not heal
  • A flat red or brownish patch that is scaly and may begin to itch
  • A shiny, pale, or waxy lump

Signs and Symptoms of Other Types of Non-Melanoma Skin Cancers

  • Sebaceous carcinoma usually appears as a small, raised, solid pimple or swelling that is yellowish and painless. The most common location is an upper eyelid, but other areas may be affected as well.
  • Merkel cell carcinoma most often appears as a painless, hard, shiny, reddish bump on areas of the skin that are exposed to the sun. The bump may be less than one-quarter inch to more than 2 inches in diameter. The cancer cells themselves lie beneath the epidermis, within the hair follicles in the dermis. The most common areas where these bumps are found are the head and neck and the arms and legs.
  • Dermatofibrosarcoma protuberans produces a flesh-colored, firm, painless growth that is about one-half to 2 inches in diameter. The cancer usually grows steadily once it first appears, and multiple lesions may ensue. Most of these growths appear on the trunk, particularly the chest and shoulders. Less often, they may occur on the head, neck, and scalp.
  • Cutaneous angiosarcoma causes firm, bluish or violet tumors that appear primarily on the scalp or upper forehead. They may appear as single growths or clusters and may bleed easily.

This content has been reviewed and approved by Myo Thant, MD.

This content was last modified on February 21, 2008 .
Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New VelcadeĀ®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health